Irene Olivera

7PUBLICATIONS
56CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 07, 2026
TNFR1 expression on cancer cells mediates immune escape and an immunosuppressive microenvironment.

|Aug 18, 2023
CD137 (4-1BB) requires physically associated cIAPs for signal transduction and antitumor effects.

Javier Glez-Vaz, Arantza Azpilikueta, María C Ochoa

|Jul 31, 2023
Facts and Hopes on Neutralization of Protumor Inflammatory Mediators in Cancer Immunotherapy.

Irene Olivera, Carlos Luri-Rey, Alvaro Teijeira

|Dec 08, 2022
Intratumoral Gene Transfer of mRNAs Encoding IL12 in Combination with Decoy-Resistant IL18 Improves Local and Systemic Antitumor Immunity.

Assunta Cirella, Elixabet Bolaños, Claudia Augusta Di Trani

|Sep 21, 2022
Depletion of Conventional Type-1 Dendritic Cells in Established Tumors Suppresses Immunotherapy Efficacy.

Alvaro Teijeira, Saray Garasa, Carlos Luri-Rey

|Jun 30, 2022
A Therapeutically Actionable Protumoral Axis of Cytokines Involving IL-8, TNFα, and IL-1β.

Irene Olivera, Rebeca Sanz-Pamplona, Elixabet Bolaños

Pageof 2

Frequent Collaborators

7 joint publications

Alvaro Teijeira

7 joint publications

Ignacio Melero

6 joint publications

Pedro Berraondo

5 joint publications

Arantza Azpilikueta